Background: Use of high-sensitivity troponin (hs-Tn) assays can detect small levels of myocardial damage previously undetectable with conventional troponin (c-Tn) assays. However, prognostic utility of these hs-Tn assays in prediction of mortality remains unclear in the presence of nonelevated c-Tn levels on admission. A systematic review and meta-analysis was performed to assess mortality risk of patients with hs-Tn elevations in the setting of normal c-Tn levels.
Hypothesis: Patients with hs-Tn elevations with normal c-Tn levels on admission blood samples, drawn to rule out acute coronary syndrome (ACS), have a higher mortality risk than those without hs-Tn or c-Tn elevations.
Methods: A search was made of the PubMed, CENTRAL, EMBASE, CINAHL, EBSCO, and Web of Science databases. Studies evaluating patients with suspected ACS that reported mortality rates for those with elevated hs-Tn levels but normal c-Tn levels on admission were included. A random-effects model was used to pool event rates, and data were reported in odds ratios (95% confidence interval).
Results: Four studies (N = 2033, mean age 64-75 years, 49%-70% male) revealed that nearly 32% of suspected ACS patients with normal c-Tn levels on admission had elevated hs-Tn levels. Elevated hs-Tn levels conferred a significantly higher risk of all-cause mortality vs normal hs-Tn levels (odds ratio: 4.35, 95% confidence interval: 2.81-6.73, P < 0.01), with negligible heterogeneity (I(2) = 0%).
Conclusions: Elevation of hs-Tn levels predicted a higher risk of mortality in patients with suspected ACS and may aid in the early identification of higher-risk patients in this setting. Future studies are needed to investigate further optimal management strategies.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649604 | PMC |
| http://dx.doi.org/10.1002/clc.22196 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Haematological Indices in Acute Coronary Syndrome Patients in Ethiopia: A Comparative Cross-Sectional Study.
J Blood Med
June 2024
Department of Biomedical Sciences, Institute of Health, Jimma University, Jimma, Oromia, Ethiopia.
Background: Numerous biomarkers are used as diagnostic, prognostic, and predictive indicators of myocardial ischemia. The most commonly used biomarkers are cardiac troponin I (Tn-I) and creatinine kinase (CK-MB). However, in developing nations, their availability in primary care settings is extremely limited.
View Article and Find Full Text PDFBiomarkers in transposition of the great arteries after arterial switch operation: A pilot trial with deep phenotyping.
Int J Cardiol
February 2024
KU Leuven, Faculty of Medicine, Leuven, Belgium; Congenital and Structural Cardiology, Leuven, Belgium; KU Leuven, Department of Cardiovascular Sciences, Leuven, Belgium. Electronic address:
Introduction: Transposition of the great arteries (TGA) is a cyanotic congenital heart defect for which the arterial switch operation (ASO) is the preferred surgical repair. This study wanted to investigate whether a panel of biomarkers could identify morphologic as well as hemodynamic changes obtained by cardiac magnetic resonance (CMR).
Methods: Forty-four adult patients were included.
Speckle tracking echocardiography in plasma cell disorders: The role of advanced imaging in the early diagnosis of AL systemic cardiac amyloidosis.
Int J Cardiol
March 2024
Department of Medical Biotechnologies, Division of Cardiology, University of Siena, Siena, Italy.
Introduction: Amyloid light-chain amyloidosis is a rare condition characterized by the abnormal production of immunoglobulin light chain that misshape and form amyloid fibrils. Over time, these amyloid deposits can accumulate slowly, causing dysfunction in organs and tissues. Early identification is crucial to ensure optimal treatment.
View Article and Find Full Text PDFChanges in circulating ApoJ-Glyc levels in patients with suspected acute coronary syndrome: The EDICA trial.
Int J Cardiol
November 2023
GlyCardial Diagnostics, S.L., Barcelona, Spain. Electronic address:
Article Synopsis
- Myocardial ischemia causes an increase in non-glycosylated apolipoprotein J, leading to lower levels of the circulating glycosylated form (ApoJ-Glyc), which may indicate transient myocardial ischemia.
- A clinical study called EDICA aimed to evaluate if changes in circulating ApoJ-Glyc could effectively detect myocardial ischemia in patients with chest pain suggestive of acute coronary syndrome.
- Results showed that ApoJ-Glyc levels were significantly lower in ischemic patients compared to non-ischemic ones, suggesting that monitoring ApoJ-Glyc could be a valuable diagnostic tool in emergency departments for detecting myocardial ischemia.
The predictive value of high sensitivity troponin measurements in patients treated with immune checkpoint inhibitors.
Clin Res Cardiol
March 2023
Division of Cardiology, Tel-Aviv Sourasky Medical Center, Affiliated to the Tel Aviv University, Tel Aviv, Israel.
Background: Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer; however, at the potential cost of serious adverse events including cardiac injury.
Objective: To assess the baseline and longitudinal changes in high sensitivity-Troponin (hs-Tn) in patients treated with pembrolizumab as a potential predictor for the development of major adverse cardiac events (MACE) and survival.
Methods: We performed a retrospective analysis of cancer patients treated with pembrolizumab at our center.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!